Schizophrenia Network

In the last years, the ECNP Schizophrenia Network has contributed to validate a state-of-the-art scale for the assessment of negative symptoms: the Brief Negative Symptom Scale (BNSS) in the pan-European study, involving 12 Countries. A self-rated instrument was also tested in the same study. The Network has a high potential of developing a common roadmap about research on schizophrenia treatment, with a focus on unmet needs, based on the research commitment of the group. The Network actively seeks to receive new members applications. We wish to have new promising young members, particularly with expertise in preclinical and clinical research, and will invite other researchers, with a special attention to gender balance.